- Sanjeev Satyal, Head of R&D of pH Phama
- Implement new technology and culture from U.S.
- Basic research for new drug candidate in Korea
- Developing glaucoma and NASH treatments
(For more information, please refer to the link below)
https://www.hankyung.com/it/article/202003033648i